Advancing cancer research, improving lives.
Pennsylvania
Joined November 2013
- Tweets13.4K
- Following1K
- Followers8.3K
- Likes10.3K
The Gilead Young Investigator Research Grant Program (RSP) supports innovative research from emerging investigators around the world to incorporate new perspectives in our pursuits of scientific understanding and progress. Learn more: ow.ly/Pbog50ZXl84
ONE WEEK AWAY! NRG will be hosting a webinar for the NRG-GI011 "LAP100" study in #PancreaticCancer and the NRG-GI012 "HELIO-RT" study in hepatocellular carcinoma with macrovascular invasion #LiverTwitter - Register here: acr-org.zoom.us/webinar/regi…
Be sure to catch the next session of the NRG Protocol Support Committee's "Discuss With Us" series on Wednesday, November 18th - the topic will be: Making RECIST/iRECIST Real: Examples You Can Use. Visit ow.ly/Cno851008Vr to learn more and to register!
Whether you are new to NRG, transitioning into a new role, or taking on different clinical trials, the NRG Mentorship Program offers personalized support from experienced NRG members. Learn more ➡️nrgoncology.org/?post_type=n…
Updated 1L mTNBC recommendations from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Breast Cancer: Click here to see the latest 1L mTNBC treatment recommendations: ow.ly/7iR550ZXkRo
Check out this webinar on therapeutic radiopharmaceuticals TODAY. Register here: ow.ly/AkjC50ZIeAHMore info below ⬇️
Join us for the next PSC “Discuss With Us” session! Colorectal Cancer Essentials: A Clinical Refresher today-Wed/Oct 21 at 2:30pm ET. If you haven’t already registered, now is a great time to join the series. Sessions are now scheduled through 2027. ow.ly/jlqz50ZUwxX
...Surviving cancer taught me to make the best of every day & appreciate the beauty in life... Cancer research is so vital & it is important for researchers to spend time listening to the patient #ParticipationPowersResearch #BreastCancer
For #BreastCancerAwarenessMonth, we’re highlighting the NRG-BR009 OFSET study, which is hoping to answer a decades old question regarding the benefit of chemotherapy, whether from cytotoxic effects or ovarian suppressive effects. Read more: ow.ly/eET350ZXkNg
This month’s Protocol Support Committee Column discusses RECIST 1.1 Documentation. Accurate RECIST 1.1 documentation supports protocol compliance, timely treatment decisions, and study data integrity. Read more: ow.ly/126550ZXkKB
NRG Oncology is currently accepting applications for travel awards to #NRG2027 in Las Vegas! Application window closes November 9th. More information can be found at ow.ly/oJEj50ZZ617
Check out the updated new protocols in development for NRG, as of the end of September: ow.ly/h3qk50ZXkHR
In this month’s Advocate Angle column, PAC vice chair, Lisa Lenrow shares her thoughts about serving in that role over the past year. ow.ly/EjHc50ZXkFm
The FORTE Study team is planning a webinar on Oct 28th to discuss the recent Amendment 9 changes to the trial. The amendment includes guidance on when unscheduled colonoscopy exams are performed.
ow.ly/WTxu50ZXkwT
@fortestudy
Dr. Priya Rastogi recently shared insights with OncLive on the evolving role of ctDNA and MRD testing in breast cancer. ow.ly/Q3Xm50ZXkw8
NRG HCA Fellowship Call for Applications Reminder (due Oct 23). ow.ly/g57x50ZXktX
NRG Oncology retweeted
Drs. @TugceKutukMD and @sarthakshah097 interview @NehaVapiwala on her leadership and advocacy through her career through to her recent ASTRO Presidency and ask for advice for physicians who are just getting started. Read the interview: rtog.org/News/Interview-with…
OlympiA trial update – results demonstrate sustained benefit of adjuvant olaparib in germline BRCA1- and BRCA2-associated high-risk HER2-negative early breast cancer. Read more: nrgoncology.org/?post_type=n…
